Eduardo Mondlane University
12
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
Role: collaborator
Expanding Health Systems Research to Optimize Hypertension Care Cascade in HIV-Infected Individuals in Mozambique
Role: lead
Rice Technologies for Cervical Cancer Screening and Diagnosis
Role: collaborator
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Role: collaborator
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Role: collaborator
A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients
Role: collaborator
Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries
Role: collaborator
Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study
Role: collaborator
SARS-CoV-2 and Acetylsalicylic Acid (SARA)
Role: collaborator
Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis
Role: collaborator
Systems Analysis and Improvement to Optimize pMTCT
Role: collaborator
The Pan African Pulmonary Hypertension Cohort Study
Role: collaborator
All 12 trials loaded